Oramed Pharmaceuticals Ratios (2011-2026) | ORMP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	May2021	Aug2021	Nov2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
Gross Margin (Quarter)				11.41%	43.62%	32.11%		72.37%	71.51%							0.65%
EBT Margin (Quarter)		-850.50%		-1,689.49%	-1,693.92%	-1,048.83%	-1,355.64%	-781.98%	-194.81%							-352.90%
EBIT Margin (Quarter)		-896.15%		-1,689.49%	-1,693.92%	-1,200.73%	-1,363.50%	-781.98%	-562.46%							-225.00%
EBITDA Margin (Quarter)		-896.15%		-1,689.49%	-1,693.92%	-1,200.73%	-1,363.50%	-781.98%	-562.46%							-225.00%
Operating Margin (Quarter)		-896.15%		-1,689.49%	-1,693.92%	-1,200.73%	-1,363.50%	-781.98%	-562.46%							-225.00%
Net Margin (Quarter)		-822.72%		-1,565.32%	-1,562.76%	-1,035.19%	-1,290.71%	-509.76%	-194.81%							-382.10%
FCF Margin (Quarter)		-428.08%		-1,377.18%	-1,262.61%	-346.33%	-925.88%	-863.06%	-393.77%							-176.10%
Efficiency
Assets Average (Quarter)	71.07M	104.25M	155.22M	177.34M	167.26M	163.36M	163.04M	160.71M	158.05M	193.60M	225.72M	212.10M	193.94M	174.65M	160.18M	151.41M	154.61M	191.09M	225.68M	249.86M
Equity Average (Quarter)	58.78M	92.32M	143.34M	166.19M	157.63M	153.09M	152.15M	150.65M	150.40M	149.44M	155.56M	164.31M	170.94M	165.84M	150.89M	143.08M	146.74M	178.43M	201.51M	219.01M
Invested Capital (Quarter)	68.18M	116.52M	170.16M	162.22M	153.04M	153.15M	151.16M	150.15M	150.66M	223.59M	213.91M	197.75M	176.15M	155.52M	146.26M	139.89M	153.58M	203.28M	199.74M	238.28M
Asset Utilization Ratio (Quarter)		0.05		0.03	0.03	0.03	0.02	0.02	0.02	0.01	0.01					0.02	0.01	0.01	0.01
Leverage & Solvency
Interest Coverage Ratio (Quarter)										-3.50	10.70	-5.00	-12.01
Debt to Equity (Quarter)	0.00									0.51	0.31	0.19
Debt Ratio (Quarter)	0.00									0.33	0.23	0.16
Equity Ratio (Quarter)	0.85	0.91	0.93	0.94	0.94	0.93	0.94	0.94	0.96	0.64	0.74	0.81	0.96	0.94	0.94	0.95	0.95	0.92	0.87	0.89
Times Interest Earned (Quarter)										-3.50	10.70	-5.00	-12.01
Dividends & Payouts
FCF Payout Ratio (Quarter)																				-3.55
Valuation
Enterprise Value (Quarter)																				-18.17M
Return Ratios
Return on Sales (Quarter)		-0.09%		-0.17%	-0.17%	-0.11%	-0.14%	-0.08%	-0.02%	-0.10%	0.03%					-0.04%	-0.12%	0.22%	0.36%
Return on Capital Employed (Quarter)																				6.96%
Return on Invested Capital (Quarter)																				0.00%
Return on Assets (Quarter)																				0.00%
Return on Equity (Quarter)																				0.01%

Research Tools

Developers

Oramed Pharmaceuticals Ratios (2011-2026) | ORMP

Research Tools

Developers

Oramed Pharmaceuticals Ratios (2011-2026) | ORMP

Create an account

Sign In

Reset Password